id	sid	tid	token	lemma	pos
dpc-1240	1	1	dermatology	dermatology	NOUN
dpc-1240	1	2	:	:	PUNCT
dpc-1240	1	3	practical	practical	ADJ
dpc-1240	1	4	and	and	CCONJ
dpc-1240	1	5	conceptual	conceptual	ADJ
dpc-1240	1	6	letter	letter	NOUN
dpc-1240	2	1	|	|	ADV
dpc-1240	2	2	dermatol	dermatol	ADJ
dpc-1240	2	3	pract	pract	NOUN
dpc-1240	2	4	concept	concept	NOUN
dpc-1240	2	5	2020;10(3):e2020061	2020;10(3):e2020061	NUM
dpc-1240	2	6	1	1	NUM
dpc-1240	2	7	dermatology	dermatology	NOUN
dpc-1240	2	8	practical	practical	ADJ
dpc-1240	2	9	&	&	CCONJ
dpc-1240	2	10	conceptual	conceptual	ADJ
dpc-1240	2	11	introduction	introduction	NOUN
dpc-1240	2	12	leishmaniasis	leishmaniasis	NOUN
dpc-1240	2	13	is	be	AUX
dpc-1240	2	14	caused	cause	VERB
dpc-1240	2	15	by	by	ADP
dpc-1240	2	16	an	an	DET
dpc-1240	2	17	intracellular	intracellular	ADJ
dpc-1240	2	18	protozoon	protozoon	NOUN
dpc-1240	2	19	and	and	CCONJ
dpc-1240	2	20	is	be	AUX
dpc-1240	2	21	characterized	characterize	VERB
dpc-1240	2	22	by	by	ADP
dpc-1240	2	23	a	a	DET
dpc-1240	2	24	broad	broad	ADJ
dpc-1240	2	25	spectrum	spectrum	NOUN
dpc-1240	2	26	of	of	ADP
dpc-1240	2	27	cutaneous	cutaneous	ADJ
dpc-1240	2	28	,	,	PUNCT
dpc-1240	2	29	mucosal	mucosal	NOUN
dpc-1240	2	30	,	,	PUNCT
dpc-1240	2	31	and	and	CCONJ
dpc-1240	2	32	systemic	systemic	ADJ
dpc-1240	2	33	presentations	presentation	NOUN
dpc-1240	3	1	[	[	X
dpc-1240	3	2	1	1	NUM
dpc-1240	3	3	]	]	PUNCT
dpc-1240	3	4	.	.	PUNCT
dpc-1240	4	1	the	the	DET
dpc-1240	4	2	clinical	clinical	ADJ
dpc-1240	4	3	manifestations	manifestation	NOUN
dpc-1240	4	4	of	of	ADP
dpc-1240	4	5	leishmaniasis	leishmaniasis	NOUN
dpc-1240	4	6	are	be	AUX
dpc-1240	4	7	determined	determine	VERB
dpc-1240	4	8	by	by	ADP
dpc-1240	4	9	the	the	DET
dpc-1240	4	10	subtype	subtype	NOUN
dpc-1240	4	11	of	of	ADP
dpc-1240	4	12	the	the	DET
dpc-1240	4	13	infectious	infectious	ADJ
dpc-1240	4	14	agent	agent	NOUN
dpc-1240	4	15	and	and	CCONJ
dpc-1240	4	16	the	the	DET
dpc-1240	4	17	immunocompetent	immunocompetent	ADJ
dpc-1240	4	18	profile	profile	NOUN
dpc-1240	4	19	of	of	ADP
dpc-1240	4	20	the	the	DET
dpc-1240	4	21	patient	patient	NOUN
dpc-1240	4	22	[	[	X
dpc-1240	4	23	1	1	NUM
dpc-1240	4	24	]	]	PUNCT
dpc-1240	4	25	.	.	PUNCT
dpc-1240	5	1	the	the	DET
dpc-1240	5	2	introduction	introduction	NOUN
dpc-1240	5	3	of	of	ADP
dpc-1240	5	4	biologics	biologic	NOUN
dpc-1240	5	5	is	be	AUX
dpc-1240	5	6	accompanied	accompany	VERB
dpc-1240	5	7	with	with	ADP
dpc-1240	5	8	impressive	impressive	ADJ
dpc-1240	5	9	therapeutic	therapeutic	ADJ
dpc-1240	5	10	outcomes	outcome	NOUN
dpc-1240	5	11	,	,	PUNCT
dpc-1240	5	12	but	but	CCONJ
dpc-1240	5	13	also	also	ADV
dpc-1240	5	14	with	with	ADP
dpc-1240	5	15	an	an	DET
dpc-1240	5	16	increase	increase	NOUN
dpc-1240	5	17	in	in	ADP
dpc-1240	5	18	the	the	DET
dpc-1240	5	19	incidence	incidence	NOUN
dpc-1240	5	20	of	of	ADP
dpc-1240	5	21	several	several	ADJ
dpc-1240	5	22	infectious	infectious	ADJ
dpc-1240	5	23	diseases	disease	NOUN
dpc-1240	5	24	[	[	X
dpc-1240	5	25	1	1	NUM
dpc-1240	5	26	]	]	PUNCT
dpc-1240	5	27	.	.	PUNCT
dpc-1240	6	1	we	we	PRON
dpc-1240	6	2	present	present	VERB
dpc-1240	6	3	the	the	DET
dpc-1240	6	4	case	case	NOUN
dpc-1240	6	5	of	of	ADP
dpc-1240	6	6	a	a	DET
dpc-1240	6	7	patient	patient	NOUN
dpc-1240	6	8	who	who	PRON
dpc-1240	6	9	developed	develop	VERB
dpc-1240	6	10	a	a	DET
dpc-1240	6	11	disseminated	disseminate	VERB
dpc-1240	6	12	cutaneous	cutaneous	ADJ
dpc-1240	6	13	leishmaniasis	leishmaniasis	NOUN
dpc-1240	6	14	infection	infection	NOUN
dpc-1240	6	15	during	during	ADP
dpc-1240	6	16	treatment	treatment	NOUN
dpc-1240	6	17	with	with	ADP
dpc-1240	6	18	adalimumab	adalimumab	NOUN
dpc-1240	6	19	.	.	PUNCT
dpc-1240	7	1	case	case	NOUN
dpc-1240	7	2	presentation	presentation	NOUN
dpc-1240	7	3	a	a	DET
dpc-1240	7	4	68	68	NUM
dpc-1240	7	5	-	-	PUNCT
dpc-1240	7	6	year	year	NOUN
dpc-1240	7	7	-	-	PUNCT
dpc-1240	7	8	old	old	ADJ
dpc-1240	7	9	man	man	NOUN
dpc-1240	7	10	from	from	ADP
dpc-1240	7	11	southwestern	southwestern	ADJ
dpc-1240	7	12	greece	greece	PROPN
dpc-1240	7	13	presented	present	VERB
dpc-1240	7	14	in	in	ADP
dpc-1240	7	15	our	our	PRON
dpc-1240	7	16	dermatology	dermatology	NOUN
dpc-1240	7	17	department	department	NOUN
dpc-1240	7	18	because	because	SCONJ
dpc-1240	7	19	of	of	ADP
dpc-1240	7	20	the	the	DET
dpc-1240	7	21	appearance	appearance	NOUN
dpc-1240	7	22	of	of	ADP
dpc-1240	7	23	10	10	NUM
dpc-1240	7	24	disseminated	disseminate	VERB
dpc-1240	7	25	,	,	PUNCT
dpc-1240	7	26	centrally	centrally	ADV
dpc-1240	7	27	erosive	erosive	ADJ
dpc-1240	7	28	,	,	PUNCT
dpc-1240	7	29	erythematous	erythematous	ADJ
dpc-1240	7	30	cutaneous	cutaneous	ADJ
dpc-1240	7	31	nodules	nodule	NOUN
dpc-1240	7	32	and	and	CCONJ
dpc-1240	7	33	plaques	plaque	NOUN
dpc-1240	7	34	,	,	PUNCT
dpc-1240	7	35	approximately	approximately	ADV
dpc-1240	7	36	1.5	1.5	NUM
dpc-1240	7	37	to	to	PART
dpc-1240	7	38	2	2	NUM
dpc-1240	7	39	cm	cm	NOUN
dpc-1240	7	40	in	in	ADP
dpc-1240	7	41	diameter	diameter	NOUN
dpc-1240	7	42	,	,	PUNCT
dpc-1240	7	43	distributed	distribute	VERB
dpc-1240	7	44	in	in	ADP
dpc-1240	7	45	the	the	DET
dpc-1240	7	46	trunk	trunk	NOUN
dpc-1240	7	47	and	and	CCONJ
dpc-1240	7	48	the	the	DET
dpc-1240	7	49	lower	low	ADJ
dpc-1240	7	50	extremities	extremity	NOUN
dpc-1240	7	51	,	,	PUNCT
dpc-1240	7	52	partially	partially	ADV
dpc-1240	7	53	in	in	ADP
dpc-1240	7	54	a	a	DET
dpc-1240	7	55	sporotrichoid	sporotrichoid	NOUN
dpc-1240	7	56	pattern	pattern	NOUN
dpc-1240	7	57	,	,	PUNCT
dpc-1240	7	58	which	which	PRON
dpc-1240	7	59	had	have	AUX
dpc-1240	7	60	been	be	AUX
dpc-1240	7	61	persistent	persistent	ADJ
dpc-1240	7	62	over	over	ADP
dpc-1240	7	63	7	7	NUM
dpc-1240	7	64	months	month	NOUN
dpc-1240	7	65	prior	prior	ADV
dpc-1240	7	66	to	to	ADP
dpc-1240	7	67	the	the	DET
dpc-1240	7	68	referral	referral	NOUN
dpc-1240	7	69	(	(	PUNCT
dpc-1240	7	70	figure	figure	NOUN
dpc-1240	7	71	1	1	NUM
dpc-1240	7	72	)	)	PUNCT
dpc-1240	7	73	.	.	PUNCT
dpc-1240	8	1	the	the	DET
dpc-1240	8	2	patient	patient	NOUN
dpc-1240	8	3	was	be	AUX
dpc-1240	8	4	a	a	DET
dpc-1240	8	5	farmer	farmer	NOUN
dpc-1240	8	6	and	and	CCONJ
dpc-1240	8	7	had	have	AUX
dpc-1240	8	8	been	be	AUX
dpc-1240	8	9	receiving	receive	VERB
dpc-1240	8	10	ongoing	ongoing	ADJ
dpc-1240	8	11	treatment	treatment	NOUN
dpc-1240	8	12	with	with	ADP
dpc-1240	8	13	methotrexate	methotrexate	NOUN
dpc-1240	8	14	(	(	PUNCT
dpc-1240	8	15	7.5	7.5	NUM
dpc-1240	8	16	mg	mg	VERB
dpc-1240	8	17	subcutaneously	subcutaneously	ADV
dpc-1240	8	18	every	every	DET
dpc-1240	8	19	week	week	NOUN
dpc-1240	8	20	)	)	PUNCT
dpc-1240	8	21	and	and	CCONJ
dpc-1240	8	22	adalimumab	adalimumab	NOUN
dpc-1240	8	23	(	(	PUNCT
dpc-1240	8	24	40	40	NUM
dpc-1240	8	25	mg	mg	VERB
dpc-1240	8	26	subcutaneously	subcutaneously	ADV
dpc-1240	8	27	every	every	DET
dpc-1240	8	28	other	other	ADJ
dpc-1240	8	29	week	week	NOUN
dpc-1240	8	30	)	)	PUNCT
dpc-1240	8	31	over	over	ADP
dpc-1240	8	32	a	a	DET
dpc-1240	8	33	period	period	NOUN
dpc-1240	8	34	of	of	ADP
dpc-1240	8	35	9	9	NUM
dpc-1240	8	36	a	a	DET
dpc-1240	8	37	rare	rare	ADJ
dpc-1240	8	38	infectious	infectious	ADJ
dpc-1240	8	39	complication	complication	NOUN
dpc-1240	8	40	of	of	ADP
dpc-1240	8	41	a	a	DET
dpc-1240	8	42	treatment	treatment	NOUN
dpc-1240	8	43	with	with	ADP
dpc-1240	8	44	biologics	biologic	NOUN
dpc-1240	8	45	:	:	PUNCT
dpc-1240	8	46	disseminated	disseminate	VERB
dpc-1240	8	47	cutaneous	cutaneous	ADJ
dpc-1240	8	48	leishmaniasis	leishmaniasis	NOUN
dpc-1240	8	49	associated	associate	VERB
dpc-1240	8	50	with	with	ADP
dpc-1240	8	51	adalimumab	adalimumab	NOUN
dpc-1240	8	52	kerasia	kerasia	PROPN
dpc-1240	8	53	-	-	PROPN
dpc-1240	8	54	maria	maria	PROPN
dpc-1240	8	55	plachouri,1	plachouri,1	PROPN
dpc-1240	8	56	maria	maria	PROPN
dpc-1240	8	57	gkermpesi,2	gkermpesi,2	PROPN
dpc-1240	8	58	eleftheria	eleftheria	PROPN
dpc-1240	8	59	vryzaki,1	vryzaki,1	X
dpc-1240	8	60	pinelopi	pinelopi	PROPN
dpc-1240	8	61	kollyrou,1	kollyrou,1	ADJ
dpc-1240	8	62	markos	markos	PROPN
dpc-1240	8	63	 	 	SPACE
dpc-1240	8	64	marangos,3	marangos,3	NOUN
dpc-1240	8	65	sophia	sophia	PROPN
dpc-1240	8	66	georgiou1	georgiou1	PROPN
dpc-1240	9	1	1	1	NUM
dpc-1240	9	2	department	department	NOUN
dpc-1240	9	3	of	of	ADP
dpc-1240	9	4	dermatology	dermatology	NOUN
dpc-1240	9	5	,	,	PUNCT
dpc-1240	9	6	university	university	NOUN
dpc-1240	9	7	general	general	ADJ
dpc-1240	9	8	hospital	hospital	NOUN
dpc-1240	9	9	of	of	ADP
dpc-1240	9	10	patras	patras	PROPN
dpc-1240	9	11	,	,	PUNCT
dpc-1240	9	12	greece	greece	PROPN
dpc-1240	9	13	2	2	NUM
dpc-1240	9	14	department	department	NOUN
dpc-1240	9	15	of	of	ADP
dpc-1240	9	16	pathology	pathology	PROPN
dpc-1240	9	17	,	,	PUNCT
dpc-1240	9	18	university	university	NOUN
dpc-1240	9	19	general	general	ADJ
dpc-1240	9	20	hospital	hospital	NOUN
dpc-1240	9	21	of	of	ADP
dpc-1240	9	22	patras	patras	PROPN
dpc-1240	9	23	,	,	PUNCT
dpc-1240	9	24	greece	greece	PROPN
dpc-1240	9	25	3	3	NUM
dpc-1240	9	26	division	division	NOUN
dpc-1240	9	27	of	of	ADP
dpc-1240	9	28	infectious	infectious	ADJ
dpc-1240	9	29	diseases	disease	NOUN
dpc-1240	9	30	,	,	PUNCT
dpc-1240	9	31	university	university	NOUN
dpc-1240	9	32	general	general	ADJ
dpc-1240	9	33	hospital	hospital	NOUN
dpc-1240	9	34	of	of	ADP
dpc-1240	9	35	patras	patras	PROPN
dpc-1240	9	36	,	,	PUNCT
dpc-1240	9	37	greece	greece	PROPN
dpc-1240	9	38	key	key	ADJ
dpc-1240	9	39	words	word	NOUN
dpc-1240	9	40	:	:	PUNCT
dpc-1240	9	41	adalimumab	adalimumab	NOUN
dpc-1240	9	42	,	,	PUNCT
dpc-1240	9	43	leishmaniasis	leishmaniasis	NOUN
dpc-1240	9	44	,	,	PUNCT
dpc-1240	9	45	immunosuppression	immunosuppression	NOUN
dpc-1240	9	46	,	,	PUNCT
dpc-1240	9	47	psoriasis	psoriasis	NOUN
dpc-1240	9	48	,	,	PUNCT
dpc-1240	9	49	biologics	biologic	NOUN
dpc-1240	9	50	citation	citation	NOUN
dpc-1240	9	51	:	:	PUNCT
dpc-1240	9	52	plachouri	plachouri	PROPN
dpc-1240	9	53	k	k	PROPN
dpc-1240	9	54	-	-	PROPN
dpc-1240	9	55	m	m	PROPN
dpc-1240	9	56	,	,	PUNCT
dpc-1240	9	57	gkermpesi	gkermpesi	NOUN
dpc-1240	9	58	m	m	PROPN
dpc-1240	9	59	,	,	PUNCT
dpc-1240	9	60	vryzaki	vryzaki	PROPN
dpc-1240	9	61	e	e	NOUN
dpc-1240	9	62	,	,	PUNCT
dpc-1240	9	63	kollyrou	kollyrou	NOUN
dpc-1240	9	64	p	p	X
dpc-1240	9	65	,	,	PUNCT
dpc-1240	9	66	marangos	marangos	PROPN
dpc-1240	9	67	m	m	PROPN
dpc-1240	9	68	,	,	PUNCT
dpc-1240	9	69	georgiou	georgiou	PROPN
dpc-1240	9	70	s.	s.	PROPN
dpc-1240	10	1	a	a	DET
dpc-1240	10	2	rare	rare	ADJ
dpc-1240	10	3	infectious	infectious	ADJ
dpc-1240	10	4	complication	complication	NOUN
dpc-1240	10	5	of	of	ADP
dpc-1240	10	6	a	a	DET
dpc-1240	10	7	treatment	treatment	NOUN
dpc-1240	10	8	with	with	ADP
dpc-1240	10	9	biologics	biologic	NOUN
dpc-1240	10	10	:	:	PUNCT
dpc-1240	10	11	disseminated	disseminate	VERB
dpc-1240	10	12	cutaneous	cutaneous	ADJ
dpc-1240	10	13	leishmaniasis	leishmaniasis	NOUN
dpc-1240	10	14	associated	associate	VERB
dpc-1240	10	15	with	with	ADP
dpc-1240	10	16	adalimumab	adalimumab	NOUN
dpc-1240	10	17	.	.	PUNCT
dpc-1240	11	1	dermatol	dermatol	NOUN
dpc-1240	11	2	pract	pract	PROPN
dpc-1240	11	3	concept	concept	NOUN
dpc-1240	11	4	.	.	PUNCT
dpc-1240	12	1	2020;10(3):e2020061	2020;10(3):e2020061	X
dpc-1240	12	2	.	.	PUNCT
dpc-1240	13	1	doi	doi	PROPN
dpc-1240	13	2	:	:	PUNCT
dpc-1240	13	3	https://doi.org/10.5826/dpc.1003a61	https://doi.org/10.5826/dpc.1003a61	PROPN
dpc-1240	13	4	accepted	accept	VERB
dpc-1240	13	5	:	:	PUNCT
dpc-1240	13	6	march	march	PROPN
dpc-1240	13	7	17	17	NUM
dpc-1240	13	8	,	,	PUNCT
dpc-1240	13	9	2020	2020	NUM
dpc-1240	13	10	;	;	PUNCT
dpc-1240	13	11	published	publish	VERB
dpc-1240	13	12	:	:	PUNCT
dpc-1240	13	13	june	june	PROPN
dpc-1240	13	14	29	29	NUM
dpc-1240	13	15	,	,	PUNCT
dpc-1240	13	16	2020	2020	NUM
dpc-1240	13	17	copyright	copyright	NOUN
dpc-1240	13	18	:	:	PUNCT
dpc-1240	14	1	©	©	PROPN
dpc-1240	14	2	2020	2020	NUM
dpc-1240	14	3	plachouri	plachouri	PROPN
dpc-1240	14	4	et	et	PROPN
dpc-1240	14	5	al	al	PROPN
dpc-1240	14	6	.	.	PUNCT
dpc-1240	15	1	this	this	PRON
dpc-1240	15	2	is	be	AUX
dpc-1240	15	3	an	an	DET
dpc-1240	15	4	open	open	ADJ
dpc-1240	15	5	-	-	PUNCT
dpc-1240	15	6	access	access	NOUN
dpc-1240	15	7	article	article	NOUN
dpc-1240	15	8	distributed	distribute	VERB
dpc-1240	15	9	under	under	ADP
dpc-1240	15	10	the	the	DET
dpc-1240	15	11	terms	term	NOUN
dpc-1240	15	12	of	of	ADP
dpc-1240	15	13	the	the	DET
dpc-1240	15	14	creative	creative	ADJ
dpc-1240	15	15	commons	common	NOUN
dpc-1240	15	16	attribution	attribution	NOUN
dpc-1240	15	17	license	license	NOUN
dpc-1240	15	18	,	,	PUNCT
dpc-1240	15	19	which	which	PRON
dpc-1240	15	20	permits	permit	VERB
dpc-1240	15	21	unrestricted	unrestricted	ADJ
dpc-1240	15	22	use	use	NOUN
dpc-1240	15	23	,	,	PUNCT
dpc-1240	15	24	distribution	distribution	NOUN
dpc-1240	15	25	,	,	PUNCT
dpc-1240	15	26	and	and	CCONJ
dpc-1240	15	27	reproduction	reproduction	NOUN
dpc-1240	15	28	in	in	ADP
dpc-1240	15	29	any	any	DET
dpc-1240	15	30	medium	medium	NOUN
dpc-1240	15	31	,	,	PUNCT
dpc-1240	15	32	provided	provide	VERB
dpc-1240	15	33	the	the	DET
dpc-1240	15	34	original	original	ADJ
dpc-1240	15	35	author	author	NOUN
dpc-1240	15	36	and	and	CCONJ
dpc-1240	15	37	source	source	NOUN
dpc-1240	15	38	are	be	AUX
dpc-1240	15	39	credited	credit	VERB
dpc-1240	15	40	.	.	PUNCT
dpc-1240	16	1	funding	funding	NOUN
dpc-1240	16	2	:	:	PUNCT
dpc-1240	16	3	none	none	NOUN
dpc-1240	16	4	.	.	PUNCT
dpc-1240	17	1	competing	compete	VERB
dpc-1240	17	2	interests	interest	NOUN
dpc-1240	17	3	:	:	PUNCT
dpc-1240	17	4	the	the	DET
dpc-1240	17	5	authors	author	NOUN
dpc-1240	17	6	have	have	VERB
dpc-1240	17	7	no	no	DET
dpc-1240	17	8	conflicts	conflict	NOUN
dpc-1240	17	9	of	of	ADP
dpc-1240	17	10	interest	interest	NOUN
dpc-1240	17	11	to	to	PART
dpc-1240	17	12	disclose	disclose	VERB
dpc-1240	17	13	.	.	PUNCT
dpc-1240	18	1	authorship	authorship	NOUN
dpc-1240	18	2	:	:	PUNCT
dpc-1240	18	3	all	all	DET
dpc-1240	18	4	authors	author	NOUN
dpc-1240	18	5	have	have	AUX
dpc-1240	18	6	contributed	contribute	VERB
dpc-1240	18	7	significantly	significantly	ADV
dpc-1240	18	8	to	to	ADP
dpc-1240	18	9	this	this	DET
dpc-1240	18	10	publication	publication	NOUN
dpc-1240	18	11	.	.	PUNCT
dpc-1240	19	1	corresponding	correspond	VERB
dpc-1240	19	2	author	author	NOUN
dpc-1240	19	3	:	:	PUNCT
dpc-1240	19	4	kerasia	kerasia	PROPN
dpc-1240	19	5	-	-	PUNCT
dpc-1240	19	6	maria	maria	PROPN
dpc-1240	19	7	plachouri	plachouri	PROPN
dpc-1240	19	8	,	,	PUNCT
dpc-1240	19	9	university	university	NOUN
dpc-1240	19	10	general	general	ADJ
dpc-1240	19	11	hospital	hospital	NOUN
dpc-1240	19	12	of	of	ADP
dpc-1240	19	13	patras	patras	PROPN
dpc-1240	19	14	,	,	PUNCT
dpc-1240	19	15	rio	rio	NOUN
dpc-1240	19	16	265	265	NUM
dpc-1240	19	17	04	04	NUM
dpc-1240	19	18	,	,	PUNCT
dpc-1240	19	19	greece	greece	PROPN
dpc-1240	19	20	.	.	PUNCT
dpc-1240	19	21	email	email	NOUN
dpc-1240	19	22	:	:	PUNCT
dpc-1240	19	23	kerasia.plachouri@	kerasia.plachouri@	X
dpc-1240	19	24	hotmail.com	hotmail.com	X
dpc-1240	19	25	figure	figure	NOUN
dpc-1240	19	26	1	1	NUM
dpc-1240	19	27	.	.	PUNCT
dpc-1240	19	28	cutaneous	cutaneous	ADJ
dpc-1240	19	29	leishmaniasis	leishmaniasis	NOUN
dpc-1240	19	30	lesions	lesion	NOUN
dpc-1240	19	31	caused	cause	VERB
dpc-1240	19	32	by	by	ADP
dpc-1240	19	33	l	l	PROPN
dpc-1240	19	34	infantum	infantum	NOUN
dpc-1240	19	35	on	on	ADP
dpc-1240	19	36	the	the	DET
dpc-1240	19	37	left	left	ADJ
dpc-1240	19	38	thigh	thigh	NOUN
dpc-1240	19	39	of	of	ADP
dpc-1240	19	40	the	the	DET
dpc-1240	19	41	patient	patient	NOUN
dpc-1240	19	42	.	.	PUNCT
dpc-1240	20	1	https://doi.org/10.5826/dpc.1003a61	https://doi.org/10.5826/dpc.1003a61	PROPN
dpc-1240	20	2	mailto:kerasia.plachouri@hotmail.com	mailto:kerasia.plachouri@hotmail.com	X
dpc-1240	20	3	mailto:kerasia.plachouri@hotmail.com	mailto:kerasia.plachouri@hotmail.com	X
dpc-1240	20	4	2	2	NUM
dpc-1240	20	5	letter	letter	NOUN
dpc-1240	21	1	|	|	ADV
dpc-1240	21	2	dermatol	dermatol	ADJ
dpc-1240	21	3	pract	pract	NOUN
dpc-1240	21	4	concept	concept	NOUN
dpc-1240	21	5	2020;10(3):e2020061	2020;10(3):e2020061	NUM
dpc-1240	21	6	adhesion	adhesion	NOUN
dpc-1240	21	7	molecules	molecule	NOUN
dpc-1240	21	8	such	such	ADJ
dpc-1240	21	9	as	as	ADP
dpc-1240	21	10	e	e	NOUN
dpc-1240	21	11	-	-	NOUN
dpc-1240	21	12	selectin	selectin	ADJ
dpc-1240	21	13	and	and	CCONJ
dpc-1240	21	14	intercellular	intercellular	ADJ
dpc-1240	21	15	adhesion	adhesion	NOUN
dpc-1240	21	16	molecule	molecule	NOUN
dpc-1240	21	17	1	1	NUM
dpc-1240	21	18	[	[	X
dpc-1240	21	19	1	1	NUM
dpc-1240	21	20	]	]	PUNCT
dpc-1240	21	21	.	.	PUNCT
dpc-1240	22	1	the	the	DET
dpc-1240	22	2	latter	latter	ADJ
dpc-1240	22	3	are	be	AUX
dpc-1240	22	4	necessary	necessary	ADJ
dpc-1240	22	5	for	for	ADP
dpc-1240	22	6	the	the	DET
dpc-1240	22	7	mononuclear	mononuclear	ADJ
dpc-1240	22	8	cell	cell	NOUN
dpc-1240	22	9	recruitment	recruitment	NOUN
dpc-1240	22	10	and	and	CCONJ
dpc-1240	22	11	the	the	DET
dpc-1240	22	12	formation	formation	NOUN
dpc-1240	22	13	of	of	ADP
dpc-1240	22	14	granulomas	granuloma	NOUN
dpc-1240	22	15	that	that	PRON
dpc-1240	22	16	enable	enable	VERB
dpc-1240	22	17	the	the	DET
dpc-1240	22	18	eradication	eradication	NOUN
dpc-1240	22	19	of	of	ADP
dpc-1240	22	20	leishmania	leishmania	NOUN
dpc-1240	22	21	spp	spp	NOUN
dpc-1240	22	22	[	[	X
dpc-1240	22	23	1	1	NUM
dpc-1240	22	24	]	]	PUNCT
dpc-1240	22	25	.	.	PUNCT
dpc-1240	23	1	forty	forty	NUM
dpc-1240	23	2	-	-	PUNCT
dpc-1240	23	3	nine	nine	NUM
dpc-1240	23	4	cases	case	NOUN
dpc-1240	23	5	of	of	ADP
dpc-1240	23	6	anti	anti	ADJ
dpc-1240	23	7	-	-	ADJ
dpc-1240	23	8	tnf	tnf	ADJ
dpc-1240	23	9	-	-	PUNCT
dpc-1240	23	10	α	α	PROPN
dpc-1240	23	11	–	–	PUNCT
dpc-1240	23	12	associated	associated	ADJ
dpc-1240	23	13	leishmaniasis	leishmaniasis	NOUN
dpc-1240	23	14	are	be	AUX
dpc-1240	23	15	published	publish	VERB
dpc-1240	23	16	in	in	ADP
dpc-1240	23	17	the	the	DET
dpc-1240	23	18	literature	literature	NOUN
dpc-1240	23	19	,	,	PUNCT
dpc-1240	23	20	28	28	NUM
dpc-1240	23	21	with	with	ADP
dpc-1240	23	22	cutaneous	cutaneous	ADJ
dpc-1240	23	23	leishmaniasis	leishmaniasis	NOUN
dpc-1240	23	24	,	,	PUNCT
dpc-1240	23	25	16	16	NUM
dpc-1240	23	26	with	with	ADP
dpc-1240	23	27	visceral	visceral	ADJ
dpc-1240	23	28	leishmaniasis	leishmaniasis	NOUN
dpc-1240	23	29	,	,	PUNCT
dpc-1240	23	30	and	and	CCONJ
dpc-1240	23	31	5	5	NUM
dpc-1240	23	32	with	with	ADP
dpc-1240	23	33	mucocutaneous	mucocutaneous	ADJ
dpc-1240	23	34	leishmaniasis	leishmaniasis	NOUN
dpc-1240	23	35	[	[	X
dpc-1240	23	36	1	1	NUM
dpc-1240	23	37	]	]	PUNCT
dpc-1240	23	38	.	.	PUNCT
dpc-1240	24	1	all	all	DET
dpc-1240	24	2	patients	patient	NOUN
dpc-1240	24	3	with	with	ADP
dpc-1240	24	4	visceral	visceral	ADJ
dpc-1240	24	5	leishmaniasis	leishmaniasis	NOUN
dpc-1240	24	6	and	and	CCONJ
dpc-1240	24	7	mucocutaneous	mucocutaneous	ADJ
dpc-1240	24	8	leishmaniasis	leishmaniasis	NOUN
dpc-1240	24	9	received	receive	VERB
dpc-1240	24	10	a	a	DET
dpc-1240	24	11	systemic	systemic	ADJ
dpc-1240	24	12	treatment	treatment	NOUN
dpc-1240	24	13	;	;	PUNCT
dpc-1240	24	14	the	the	DET
dpc-1240	24	15	therapy	therapy	NOUN
dpc-1240	24	16	of	of	ADP
dpc-1240	24	17	choice	choice	NOUN
dpc-1240	24	18	was	be	AUX
dpc-1240	24	19	in	in	ADP
dpc-1240	24	20	most	most	ADJ
dpc-1240	24	21	cases	case	NOUN
dpc-1240	24	22	intravenous	intravenous	ADJ
dpc-1240	24	23	liposomal	liposomal	NOUN
dpc-1240	24	24	amphotericin	amphotericin	ADP
dpc-1240	24	25	b	b	NOUN
dpc-1240	24	26	in	in	ADP
dpc-1240	24	27	various	various	ADJ
dpc-1240	24	28	dosage	dosage	NOUN
dpc-1240	24	29	regimens	regimen	NOUN
dpc-1240	24	30	with	with	ADP
dpc-1240	24	31	a	a	DET
dpc-1240	24	32	cumulative	cumulative	ADJ
dpc-1240	24	33	dose	dose	NOUN
dpc-1240	24	34	ranging	range	VERB
dpc-1240	24	35	from	from	ADP
dpc-1240	24	36	15.4	15.4	NUM
dpc-1240	24	37	mg	mg	NOUN
dpc-1240	24	38	/	/	SYM
dpc-1240	24	39	kg	kg	NOUN
dpc-1240	24	40	to	to	ADP
dpc-1240	24	41	50	50	NUM
dpc-1240	24	42	mg	mg	PROPN
dpc-1240	24	43	/	/	SYM
dpc-1240	24	44	kg	kg	PROPN
dpc-1240	24	45	,	,	PUNCT
dpc-1240	24	46	while	while	SCONJ
dpc-1240	24	47	less	less	ADV
dpc-1240	24	48	frequently	frequently	ADV
dpc-1240	24	49	parenteral	parenteral	ADJ
dpc-1240	24	50	pentavalent	pentavalent	NOUN
dpc-1240	24	51	antimonials	antimonial	NOUN
dpc-1240	24	52	and	and	CCONJ
dpc-1240	24	53	miltefosine	miltefosine	NOUN
dpc-1240	24	54	were	be	AUX
dpc-1240	24	55	also	also	ADV
dpc-1240	24	56	administered	administer	VERB
dpc-1240	24	57	[	[	PUNCT
dpc-1240	24	58	1	1	NUM
dpc-1240	24	59	]	]	PUNCT
dpc-1240	24	60	.	.	PUNCT
dpc-1240	25	1	half	half	NOUN
dpc-1240	25	2	of	of	ADP
dpc-1240	25	3	the	the	DET
dpc-1240	25	4	patients	patient	NOUN
dpc-1240	25	5	with	with	ADP
dpc-1240	25	6	cutaneous	cutaneous	ADJ
dpc-1240	25	7	leishmaniasis	leishmaniasis	NOUN
dpc-1240	25	8	received	receive	VERB
dpc-1240	25	9	a	a	DET
dpc-1240	25	10	systemic	systemic	ADJ
dpc-1240	25	11	treatment	treatment	NOUN
dpc-1240	25	12	with	with	ADP
dpc-1240	25	13	liposomal	liposomal	NOUN
dpc-1240	25	14	amphotericin	amphotericin	ADP
dpc-1240	25	15	b	b	NOUN
dpc-1240	25	16	as	as	ADV
dpc-1240	25	17	well	well	ADV
dpc-1240	25	18	,	,	PUNCT
dpc-1240	25	19	while	while	SCONJ
dpc-1240	25	20	the	the	DET
dpc-1240	25	21	rest	rest	NOUN
dpc-1240	25	22	of	of	ADP
dpc-1240	25	23	the	the	DET
dpc-1240	25	24	cases	case	NOUN
dpc-1240	25	25	were	be	AUX
dpc-1240	25	26	treated	treat	VERB
dpc-1240	25	27	with	with	ADP
dpc-1240	25	28	intralesional	intralesional	ADJ
dpc-1240	25	29	pentavalent	pentavalent	NOUN
dpc-1240	25	30	antimonials	antimonial	NOUN
dpc-1240	25	31	,	,	PUNCT
dpc-1240	25	32	occasionally	occasionally	ADV
dpc-1240	25	33	combined	combine	VERB
dpc-1240	25	34	with	with	ADP
dpc-1240	25	35	surgical	surgical	ADJ
dpc-1240	25	36	excision	excision	NOUN
dpc-1240	25	37	or	or	CCONJ
dpc-1240	25	38	cryotherapy	cryotherapy	NOUN
dpc-1240	26	1	[	[	X
dpc-1240	26	2	1	1	NUM
dpc-1240	26	3	]	]	PUNCT
dpc-1240	26	4	.	.	PUNCT
dpc-1240	27	1	it	it	PRON
dpc-1240	27	2	is	be	AUX
dpc-1240	27	3	interesting	interesting	ADJ
dpc-1240	27	4	that	that	SCONJ
dpc-1240	27	5	the	the	DET
dpc-1240	27	6	tnf	tnf	PROPN
dpc-1240	27	7	-	-	PUNCT
dpc-1240	27	8	α	α	PROPN
dpc-1240	27	9	inhibitor	inhibitor	NOUN
dpc-1240	27	10	treatment	treatment	NOUN
dpc-1240	27	11	had	have	VERB
dpc-1240	27	12	to	to	PART
dpc-1240	27	13	be	be	AUX
dpc-1240	27	14	stopped	stop	VERB
dpc-1240	27	15	in	in	ADP
dpc-1240	27	16	only	only	ADV
dpc-1240	27	17	32	32	NUM
dpc-1240	27	18	of	of	ADP
dpc-1240	27	19	the	the	DET
dpc-1240	27	20	reported	report	VERB
dpc-1240	27	21	cases	case	NOUN
dpc-1240	27	22	[	[	X
dpc-1240	27	23	1	1	NUM
dpc-1240	27	24	]	]	PUNCT
dpc-1240	27	25	.	.	PUNCT
dpc-1240	28	1	all	all	DET
dpc-1240	28	2	patients	patient	NOUN
dpc-1240	28	3	showed	show	VERB
dpc-1240	28	4	a	a	DET
dpc-1240	28	5	full	full	ADJ
dpc-1240	28	6	recovery	recovery	NOUN
dpc-1240	28	7	,	,	PUNCT
dpc-1240	28	8	but	but	CCONJ
dpc-1240	28	9	relapses	relapse	NOUN
dpc-1240	28	10	were	be	AUX
dpc-1240	28	11	reported	report	VERB
dpc-1240	28	12	in	in	ADP
dpc-1240	28	13	3	3	NUM
dpc-1240	28	14	patients	patient	NOUN
dpc-1240	28	15	treated	treat	VERB
dpc-1240	28	16	with	with	ADP
dpc-1240	28	17	intralesional	intralesional	ADJ
dpc-1240	28	18	pentavalent	pentavalent	NOUN
dpc-1240	28	19	antimonials	antimonial	NOUN
dpc-1240	28	20	,	,	PUNCT
dpc-1240	29	1	1	1	NUM
dpc-1240	29	2	patient	patient	NOUN
dpc-1240	29	3	treated	treat	VERB
dpc-1240	29	4	with	with	ADP
dpc-1240	29	5	surgery	surgery	NOUN
dpc-1240	29	6	,	,	PUNCT
dpc-1240	29	7	and	and	CCONJ
dpc-1240	29	8	only	only	ADV
dpc-1240	29	9	2	2	NUM
dpc-1240	29	10	patients	patient	NOUN
dpc-1240	29	11	treated	treat	VERB
dpc-1240	29	12	with	with	ADP
dpc-1240	29	13	systemic	systemic	ADJ
dpc-1240	29	14	liposomal	liposomal	NOUN
dpc-1240	29	15	amphotericin	amphotericin	ADP
dpc-1240	29	16	b	b	NOUN
dpc-1240	29	17	and	and	CCONJ
dpc-1240	29	18	miltefosine	miltefosine	NOUN
dpc-1240	29	19	,	,	PUNCT
dpc-1240	29	20	respectively	respectively	ADV
dpc-1240	29	21	[	[	X
dpc-1240	29	22	1	1	NUM
dpc-1240	29	23	]	]	PUNCT
dpc-1240	29	24	.	.	PUNCT
dpc-1240	30	1	although	although	SCONJ
dpc-1240	30	2	these	these	DET
dpc-1240	30	3	data	datum	NOUN
dpc-1240	30	4	seem	seem	VERB
dpc-1240	30	5	relevant	relevant	ADJ
dpc-1240	30	6	only	only	ADV
dpc-1240	30	7	for	for	ADP
dpc-1240	30	8	areas	area	NOUN
dpc-1240	30	9	where	where	SCONJ
dpc-1240	30	10	these	these	DET
dpc-1240	30	11	infectious	infectious	ADJ
dpc-1240	30	12	diseases	disease	NOUN
dpc-1240	30	13	are	be	AUX
dpc-1240	30	14	endemic	endemic	ADJ
dpc-1240	30	15	,	,	PUNCT
dpc-1240	30	16	such	such	ADJ
dpc-1240	30	17	as	as	ADP
dpc-1240	30	18	south	south	PROPN
dpc-1240	30	19	europe	europe	PROPN
dpc-1240	30	20	and	and	CCONJ
dpc-1240	30	21	south	south	PROPN
dpc-1240	30	22	america	america	PROPN
dpc-1240	30	23	,	,	PUNCT
dpc-1240	30	24	one	one	PRON
dpc-1240	30	25	can	can	AUX
dpc-1240	30	26	not	not	PART
dpc-1240	30	27	underestimate	underestimate	VERB
dpc-1240	30	28	the	the	DET
dpc-1240	30	29	fact	fact	NOUN
dpc-1240	30	30	that	that	SCONJ
dpc-1240	30	31	the	the	DET
dpc-1240	30	32	massive	massive	ADJ
dpc-1240	30	33	human	human	ADJ
dpc-1240	30	34	migration	migration	NOUN
dpc-1240	30	35	for	for	ADP
dpc-1240	30	36	socioeconomic	socioeconomic	ADJ
dpc-1240	30	37	reasons	reason	NOUN
dpc-1240	30	38	may	may	AUX
dpc-1240	30	39	gradually	gradually	ADV
dpc-1240	30	40	change	change	VERB
dpc-1240	30	41	the	the	DET
dpc-1240	30	42	epidemiological	epidemiological	ADJ
dpc-1240	30	43	and	and	CCONJ
dpc-1240	30	44	demographic	demographic	ADJ
dpc-1240	30	45	aspects	aspect	NOUN
dpc-1240	30	46	of	of	ADP
dpc-1240	30	47	infectious	infectious	ADJ
dpc-1240	30	48	diseases	disease	NOUN
dpc-1240	30	49	[	[	X
dpc-1240	30	50	2	2	NUM
dpc-1240	30	51	]	]	PUNCT
dpc-1240	30	52	.	.	PUNCT
dpc-1240	31	1	it	it	PRON
dpc-1240	31	2	is	be	AUX
dpc-1240	31	3	necessary	necessary	ADJ
dpc-1240	31	4	for	for	SCONJ
dpc-1240	31	5	physicians	physician	NOUN
dpc-1240	31	6	to	to	PART
dpc-1240	31	7	gain	gain	VERB
dpc-1240	31	8	familiarity	familiarity	NOUN
dpc-1240	31	9	with	with	ADP
dpc-1240	31	10	leishmaniasis	leishmaniasis	NOUN
dpc-1240	31	11	and	and	CCONJ
dpc-1240	31	12	to	to	PART
dpc-1240	31	13	maintain	maintain	VERB
dpc-1240	31	14	a	a	DET
dpc-1240	31	15	high	high	ADJ
dpc-1240	31	16	level	level	NOUN
dpc-1240	31	17	of	of	ADP
dpc-1240	31	18	suspicion	suspicion	NOUN
dpc-1240	31	19	,	,	PUNCT
dpc-1240	31	20	especially	especially	ADV
dpc-1240	31	21	in	in	ADP
dpc-1240	31	22	iatrogenically	iatrogenically	ADV
dpc-1240	31	23	immunosuppressed	immunosuppressed	ADJ
dpc-1240	31	24	patients	patient	NOUN
dpc-1240	31	25	,	,	PUNCT
dpc-1240	31	26	in	in	ADP
dpc-1240	31	27	order	order	NOUN
dpc-1240	31	28	to	to	PART
dpc-1240	31	29	reach	reach	VERB
dpc-1240	31	30	an	an	DET
dpc-1240	31	31	early	early	ADJ
dpc-1240	31	32	diagnosis	diagnosis	NOUN
dpc-1240	31	33	and	and	CCONJ
dpc-1240	31	34	thus	thus	ADV
dpc-1240	31	35	prevent	prevent	VERB
dpc-1240	31	36	disease	disease	NOUN
dpc-1240	31	37	-	-	PUNCT
dpc-1240	31	38	related	relate	VERB
dpc-1240	31	39	complications	complication	NOUN
dpc-1240	31	40	as	as	ADV
dpc-1240	31	41	well	well	ADV
dpc-1240	31	42	as	as	ADP
dpc-1240	31	43	disease	disease	NOUN
dpc-1240	31	44	transmission	transmission	NOUN
dpc-1240	31	45	in	in	ADP
dpc-1240	31	46	nonendemic	nonendemic	ADJ
dpc-1240	31	47	areas	area	NOUN
dpc-1240	31	48	[	[	X
dpc-1240	31	49	2	2	NUM
dpc-1240	31	50	]	]	PUNCT
dpc-1240	31	51	.	.	PUNCT
dpc-1240	32	1	years	year	NOUN
dpc-1240	32	2	for	for	ADP
dpc-1240	32	3	plaque	plaque	NOUN
dpc-1240	32	4	psoriasis	psoriasis	NOUN
dpc-1240	32	5	and	and	CCONJ
dpc-1240	32	6	psoriatic	psoriatic	ADJ
dpc-1240	32	7	arthritis	arthritis	NOUN
dpc-1240	32	8	.	.	PUNCT
dpc-1240	33	1	at	at	ADP
dpc-1240	33	2	the	the	DET
dpc-1240	33	3	time	time	NOUN
dpc-1240	33	4	of	of	ADP
dpc-1240	33	5	presentation	presentation	NOUN
dpc-1240	33	6	both	both	DET
dpc-1240	33	7	diseases	disease	NOUN
dpc-1240	33	8	were	be	AUX
dpc-1240	33	9	in	in	ADP
dpc-1240	33	10	long	long	ADJ
dpc-1240	33	11	-	-	PUNCT
dpc-1240	33	12	term	term	NOUN
dpc-1240	33	13	remission	remission	NOUN
dpc-1240	33	14	,	,	PUNCT
dpc-1240	33	15	with	with	ADP
dpc-1240	33	16	no	no	DET
dpc-1240	33	17	signs	sign	NOUN
dpc-1240	33	18	of	of	ADP
dpc-1240	33	19	cutaneous	cutaneous	ADJ
dpc-1240	33	20	psoriatic	psoriatic	ADJ
dpc-1240	33	21	lesions	lesion	NOUN
dpc-1240	33	22	,	,	PUNCT
dpc-1240	33	23	lymphadenopathy	lymphadenopathy	ADJ
dpc-1240	33	24	,	,	PUNCT
dpc-1240	33	25	or	or	CCONJ
dpc-1240	33	26	arthritis	arthritis	NOUN
dpc-1240	33	27	during	during	ADP
dpc-1240	33	28	the	the	DET
dpc-1240	33	29	physical	physical	ADJ
dpc-1240	33	30	examination	examination	NOUN
dpc-1240	33	31	.	.	PUNCT
dpc-1240	34	1	the	the	DET
dpc-1240	34	2	histopathological	histopathological	ADJ
dpc-1240	34	3	examination	examination	NOUN
dpc-1240	34	4	of	of	ADP
dpc-1240	34	5	one	one	NUM
dpc-1240	34	6	of	of	ADP
dpc-1240	34	7	the	the	DET
dpc-1240	34	8	skin	skin	NOUN
dpc-1240	34	9	lesions	lesion	NOUN
dpc-1240	34	10	showed	show	VERB
dpc-1240	34	11	evidence	evidence	NOUN
dpc-1240	34	12	of	of	ADP
dpc-1240	34	13	a	a	DET
dpc-1240	34	14	leishmania	leishmania	NOUN
dpc-1240	34	15	spp	spp	NOUN
dpc-1240	34	16	infection	infection	NOUN
dpc-1240	34	17	(	(	PUNCT
dpc-1240	34	18	figure	figure	NOUN
dpc-1240	34	19	2	2	NUM
dpc-1240	34	20	)	)	PUNCT
dpc-1240	34	21	.	.	PUNCT
dpc-1240	35	1	the	the	DET
dpc-1240	35	2	agent	agent	NOUN
dpc-1240	35	3	was	be	AUX
dpc-1240	35	4	identified	identify	VERB
dpc-1240	35	5	as	as	ADP
dpc-1240	35	6	l	l	PROPN
dpc-1240	35	7	infantum	infantum	NOUN
dpc-1240	35	8	,	,	PUNCT
dpc-1240	35	9	using	use	VERB
dpc-1240	35	10	the	the	DET
dpc-1240	35	11	polymerase	polymerase	NOUN
dpc-1240	35	12	chain	chain	NOUN
dpc-1240	35	13	reaction	reaction	NOUN
dpc-1240	35	14	(	(	PUNCT
dpc-1240	35	15	pcr	pcr	NOUN
dpc-1240	35	16	)	)	PUNCT
dpc-1240	35	17	technique	technique	NOUN
dpc-1240	35	18	in	in	ADP
dpc-1240	35	19	a	a	DET
dpc-1240	35	20	skin	skin	NOUN
dpc-1240	35	21	biopsy	biopsy	NOUN
dpc-1240	35	22	sample	sample	NOUN
dpc-1240	35	23	.	.	PUNCT
dpc-1240	36	1	the	the	DET
dpc-1240	36	2	screening	screening	NOUN
dpc-1240	36	3	for	for	ADP
dpc-1240	36	4	visceral	visceral	ADJ
dpc-1240	36	5	leishmaniasis	leishmaniasis	NOUN
dpc-1240	36	6	,	,	PUNCT
dpc-1240	36	7	which	which	PRON
dpc-1240	36	8	included	include	VERB
dpc-1240	36	9	the	the	DET
dpc-1240	36	10	measurement	measurement	NOUN
dpc-1240	36	11	of	of	ADP
dpc-1240	36	12	antibodies	antibody	NOUN
dpc-1240	36	13	against	against	ADP
dpc-1240	36	14	the	the	DET
dpc-1240	36	15	recombinant	recombinant	ADJ
dpc-1240	36	16	k39	k39	NOUN
dpc-1240	36	17	antigen	antigen	ADV
dpc-1240	36	18	,	,	PUNCT
dpc-1240	36	19	the	the	DET
dpc-1240	36	20	specific	specific	ADJ
dpc-1240	36	21	anti	anti	ADJ
dpc-1240	36	22	-	-	ADJ
dpc-1240	36	23	leishmania	leishmania	ADJ
dpc-1240	36	24	antibody	antibody	NOUN
dpc-1240	36	25	titers	titer	NOUN
dpc-1240	36	26	in	in	ADP
dpc-1240	36	27	blood	blood	NOUN
dpc-1240	36	28	serum	serum	NOUN
dpc-1240	36	29	,	,	PUNCT
dpc-1240	36	30	as	as	ADV
dpc-1240	36	31	well	well	ADV
dpc-1240	36	32	as	as	ADP
dpc-1240	36	33	pcr	pcr	ADJ
dpc-1240	36	34	in	in	ADP
dpc-1240	36	35	a	a	DET
dpc-1240	36	36	bone	bone	NOUN
dpc-1240	36	37	marrow	marrow	NOUN
dpc-1240	36	38	aspirate	aspirate	NOUN
dpc-1240	36	39	sample	sample	NOUN
dpc-1240	36	40	,	,	PUNCT
dpc-1240	36	41	showed	show	VERB
dpc-1240	36	42	no	no	DET
dpc-1240	36	43	leishmania	leishmania	NOUN
dpc-1240	36	44	-	-	PUNCT
dpc-1240	36	45	associated	associate	VERB
dpc-1240	36	46	findings	finding	NOUN
dpc-1240	36	47	.	.	PUNCT
dpc-1240	37	1	an	an	DET
dpc-1240	37	2	ultrasound	ultrasound	NOUN
dpc-1240	37	3	examination	examination	NOUN
dpc-1240	37	4	showed	show	VERB
dpc-1240	37	5	no	no	DET
dpc-1240	37	6	signs	sign	NOUN
dpc-1240	37	7	of	of	ADP
dpc-1240	37	8	hepatosplenomegaly	hepatosplenomegaly	NOUN
dpc-1240	37	9	and	and	CCONJ
dpc-1240	37	10	a	a	DET
dpc-1240	37	11	chest	chest	NOUN
dpc-1240	37	12	x	x	NOUN
dpc-1240	37	13	-	-	NOUN
dpc-1240	37	14	ray	ray	NOUN
dpc-1240	37	15	revealed	reveal	VERB
dpc-1240	37	16	no	no	DET
dpc-1240	37	17	abnormal	abnormal	ADJ
dpc-1240	37	18	findings	finding	NOUN
dpc-1240	37	19	.	.	PUNCT
dpc-1240	38	1	owing	owe	VERB
dpc-1240	38	2	to	to	ADP
dpc-1240	38	3	the	the	DET
dpc-1240	38	4	occurrence	occurrence	NOUN
dpc-1240	38	5	of	of	ADP
dpc-1240	38	6	10	10	NUM
dpc-1240	38	7	or	or	CCONJ
dpc-1240	38	8	more	more	ADJ
dpc-1240	38	9	disseminated	disseminate	VERB
dpc-1240	38	10	lesions	lesion	NOUN
dpc-1240	38	11	in	in	ADP
dpc-1240	38	12	more	more	ADJ
dpc-1240	38	13	than	than	ADP
dpc-1240	38	14	2	2	NUM
dpc-1240	38	15	noncontinuous	noncontinuous	ADJ
dpc-1240	38	16	anatomic	anatomic	ADJ
dpc-1240	38	17	locations	location	NOUN
dpc-1240	38	18	,	,	PUNCT
dpc-1240	38	19	the	the	DET
dpc-1240	38	20	condition	condition	NOUN
dpc-1240	38	21	was	be	AUX
dpc-1240	38	22	characterized	characterize	VERB
dpc-1240	38	23	as	as	ADP
dpc-1240	38	24	a	a	DET
dpc-1240	38	25	disseminated	disseminate	VERB
dpc-1240	38	26	cutaneous	cutaneous	ADJ
dpc-1240	38	27	leishmaniasis	leishmaniasis	NOUN
dpc-1240	38	28	.	.	PUNCT
dpc-1240	39	1	the	the	DET
dpc-1240	39	2	treatment	treatment	NOUN
dpc-1240	39	3	with	with	ADP
dpc-1240	39	4	adalimumab	adalimumab	NOUN
dpc-1240	39	5	and	and	CCONJ
dpc-1240	39	6	methotrexate	methotrexate	NOUN
dpc-1240	39	7	was	be	AUX
dpc-1240	39	8	interrupted	interrupted	ADJ
dpc-1240	39	9	and	and	CCONJ
dpc-1240	39	10	treatment	treatment	NOUN
dpc-1240	39	11	with	with	ADP
dpc-1240	39	12	liposomal	liposomal	NOUN
dpc-1240	39	13	amphotericin	amphotericin	ADP
dpc-1240	39	14	b	b	PROPN
dpc-1240	39	15	was	be	AUX
dpc-1240	39	16	initiated	initiate	VERB
dpc-1240	39	17	(	(	PUNCT
dpc-1240	39	18	3	3	NUM
dpc-1240	39	19	mg	mg	PROPN
dpc-1240	39	20	/	/	SYM
dpc-1240	39	21	kg	kg	PROPN
dpc-1240	39	22	/	/	SYM
dpc-1240	39	23	day	day	NOUN
dpc-1240	39	24	,	,	PUNCT
dpc-1240	39	25	administered	administer	VERB
dpc-1240	39	26	intravenously	intravenously	ADV
dpc-1240	39	27	on	on	ADP
dpc-1240	39	28	days	day	NOUN
dpc-1240	39	29	1	1	NUM
dpc-1240	39	30	-	-	SYM
dpc-1240	39	31	5	5	NUM
dpc-1240	39	32	,	,	PUNCT
dpc-1240	39	33	10	10	NUM
dpc-1240	39	34	,	,	PUNCT
dpc-1240	39	35	17	17	NUM
dpc-1240	39	36	,	,	PUNCT
dpc-1240	39	37	24	24	NUM
dpc-1240	39	38	,	,	PUNCT
dpc-1240	39	39	31	31	NUM
dpc-1240	39	40	,	,	PUNCT
dpc-1240	39	41	and	and	CCONJ
dpc-1240	39	42	38	38	NUM
dpc-1240	39	43	)	)	PUNCT
dpc-1240	39	44	.	.	PUNCT
dpc-1240	40	1	the	the	DET
dpc-1240	40	2	therapy	therapy	NOUN
dpc-1240	40	3	was	be	AUX
dpc-1240	40	4	well	well	ADV
dpc-1240	40	5	tolerated	tolerate	VERB
dpc-1240	40	6	.	.	PUNCT
dpc-1240	41	1	in	in	ADP
dpc-1240	41	2	the	the	DET
dpc-1240	41	3	24	24	NUM
dpc-1240	41	4	-	-	PUNCT
dpc-1240	41	5	month	month	NOUN
dpc-1240	41	6	follow	follow	NOUN
dpc-1240	41	7	-	-	PUNCT
dpc-1240	41	8	up	up	NOUN
dpc-1240	41	9	the	the	DET
dpc-1240	41	10	patient	patient	NOUN
dpc-1240	41	11	remained	remain	VERB
dpc-1240	41	12	asymptomatic	asymptomatic	ADJ
dpc-1240	41	13	,	,	PUNCT
dpc-1240	41	14	with	with	ADP
dpc-1240	41	15	almost	almost	ADV
dpc-1240	41	16	total	total	ADJ
dpc-1240	41	17	clearance	clearance	NOUN
dpc-1240	41	18	of	of	ADP
dpc-1240	41	19	the	the	DET
dpc-1240	41	20	cutaneous	cutaneous	ADJ
dpc-1240	41	21	lesions	lesion	NOUN
dpc-1240	41	22	(	(	PUNCT
dpc-1240	41	23	figure	figure	NOUN
dpc-1240	41	24	3	3	NUM
dpc-1240	41	25	)	)	PUNCT
dpc-1240	41	26	.	.	PUNCT
dpc-1240	42	1	adalimumab	adalimumab	NOUN
dpc-1240	42	2	was	be	AUX
dpc-1240	42	3	reinitiated	reinitiate	VERB
dpc-1240	42	4	1.5	1.5	NUM
dpc-1240	42	5	years	year	NOUN
dpc-1240	42	6	after	after	ADP
dpc-1240	42	7	the	the	DET
dpc-1240	42	8	successful	successful	ADJ
dpc-1240	42	9	eradication	eradication	NOUN
dpc-1240	42	10	of	of	ADP
dpc-1240	42	11	leishmaniasis	leishmaniasis	NOUN
dpc-1240	42	12	,	,	PUNCT
dpc-1240	42	13	with	with	ADP
dpc-1240	42	14	no	no	DET
dpc-1240	42	15	signs	sign	NOUN
dpc-1240	42	16	of	of	ADP
dpc-1240	42	17	recurrence	recurrence	NOUN
dpc-1240	42	18	over	over	ADP
dpc-1240	42	19	the	the	DET
dpc-1240	42	20	48	48	NUM
dpc-1240	42	21	-	-	PUNCT
dpc-1240	42	22	month	month	NOUN
dpc-1240	42	23	follow	follow	NOUN
dpc-1240	42	24	-	-	PUNCT
dpc-1240	42	25	up	up	NOUN
dpc-1240	42	26	(	(	PUNCT
dpc-1240	42	27	figure	figure	NOUN
dpc-1240	42	28	3	3	NUM
dpc-1240	42	29	)	)	PUNCT
dpc-1240	42	30	.	.	PUNCT
dpc-1240	43	1	conclusions	conclusion	NOUN
dpc-1240	43	2	in	in	ADP
dpc-1240	43	3	the	the	DET
dpc-1240	43	4	era	era	NOUN
dpc-1240	43	5	of	of	ADP
dpc-1240	43	6	biologics	biologic	NOUN
dpc-1240	43	7	,	,	PUNCT
dpc-1240	43	8	physicians	physician	NOUN
dpc-1240	43	9	often	often	ADV
dpc-1240	43	10	witness	witness	VERB
dpc-1240	43	11	the	the	DET
dpc-1240	43	12	reactivation	reactivation	NOUN
dpc-1240	43	13	of	of	ADP
dpc-1240	43	14	latent	latent	NOUN
dpc-1240	43	15	infections	infection	NOUN
dpc-1240	43	16	,	,	PUNCT
dpc-1240	43	17	such	such	ADJ
dpc-1240	43	18	as	as	ADP
dpc-1240	43	19	tuberculosis	tuberculosis	NOUN
dpc-1240	43	20	or	or	CCONJ
dpc-1240	43	21	leishmaniasis	leishmaniasis	NOUN
dpc-1240	43	22	[	[	X
dpc-1240	43	23	1	1	NUM
dpc-1240	43	24	]	]	PUNCT
dpc-1240	43	25	.	.	PUNCT
dpc-1240	44	1	when	when	SCONJ
dpc-1240	44	2	it	it	PRON
dpc-1240	44	3	comes	come	VERB
dpc-1240	44	4	to	to	ADP
dpc-1240	44	5	leishmaniasis	leishmaniasis	NOUN
dpc-1240	44	6	in	in	ADP
dpc-1240	44	7	relation	relation	NOUN
dpc-1240	44	8	to	to	ADP
dpc-1240	44	9	tumor	tumor	NOUN
dpc-1240	44	10	necrosis	necrosis	NOUN
dpc-1240	44	11	factor	factor	NOUN
dpc-1240	44	12	alpha	alpha	NOUN
dpc-1240	44	13	(	(	PUNCT
dpc-1240	44	14	tnf	tnf	PROPN
dpc-1240	44	15	-	-	PUNCT
dpc-1240	44	16	α	α	NOUN
dpc-1240	44	17	)	)	PUNCT
dpc-1240	44	18	inhibitors	inhibitor	NOUN
dpc-1240	44	19	,	,	PUNCT
dpc-1240	44	20	one	one	NUM
dpc-1240	44	21	of	of	ADP
dpc-1240	44	22	the	the	DET
dpc-1240	44	23	suggested	suggest	VERB
dpc-1240	44	24	pathogenetic	pathogenetic	ADJ
dpc-1240	44	25	mechanisms	mechanism	NOUN
dpc-1240	44	26	of	of	ADP
dpc-1240	44	27	infection	infection	NOUN
dpc-1240	44	28	is	be	AUX
dpc-1240	44	29	believed	believe	VERB
dpc-1240	44	30	to	to	PART
dpc-1240	44	31	be	be	AUX
dpc-1240	44	32	a	a	DET
dpc-1240	44	33	tnf	tnf	PROPN
dpc-1240	44	34	-	-	PUNCT
dpc-1240	44	35	α	α	NOUN
dpc-1240	44	36	inhibitor	inhibitor	NOUN
dpc-1240	44	37	–	–	PUNCT
dpc-1240	44	38	mediated	mediate	VERB
dpc-1240	44	39	downregulation	downregulation	NOUN
dpc-1240	44	40	of	of	ADP
dpc-1240	44	41	endothelial	endothelial	ADJ
dpc-1240	44	42	figure	figure	NOUN
dpc-1240	44	43	2	2	NUM
dpc-1240	44	44	.	.	PUNCT
dpc-1240	44	45	histopathological	histopathological	ADJ
dpc-1240	44	46	image	image	NOUN
dpc-1240	44	47	of	of	ADP
dpc-1240	44	48	cutaneous	cutaneous	ADJ
dpc-1240	44	49	leishmaniasis	leishmaniasis	NOUN
dpc-1240	44	50	.	.	PUNCT
dpc-1240	45	1	dense	dense	ADJ
dpc-1240	45	2	dermal	dermal	NOUN
dpc-1240	45	3	infiltrate	infiltrate	NOUN
dpc-1240	45	4	of	of	ADP
dpc-1240	45	5	large	large	ADJ
dpc-1240	45	6	histiocytes	histiocyte	NOUN
dpc-1240	45	7	.	.	PUNCT
dpc-1240	46	1	leishman	leishman	NOUN
dpc-1240	46	2	-	-	PUNCT
dpc-1240	46	3	donovan	donovan	PROPN
dpc-1240	46	4	bodies	body	NOUN
dpc-1240	46	5	are	be	AUX
dpc-1240	46	6	found	find	VERB
dpc-1240	46	7	in	in	ADP
dpc-1240	46	8	histiocytes	histiocyte	NOUN
dpc-1240	46	9	,	,	PUNCT
dpc-1240	46	10	lining	line	VERB
dpc-1240	46	11	their	their	PRON
dpc-1240	46	12	internal	internal	ADJ
dpc-1240	46	13	membrane	membrane	NOUN
dpc-1240	46	14	(	(	PUNCT
dpc-1240	46	15	arrow	arrow	NOUN
dpc-1240	46	16	)	)	PUNCT
dpc-1240	46	17	.	.	PUNCT
dpc-1240	47	1	an	an	DET
dpc-1240	47	2	admixture	admixture	NOUN
dpc-1240	47	3	of	of	ADP
dpc-1240	47	4	lymphocytes	lymphocyte	NOUN
dpc-1240	47	5	,	,	PUNCT
dpc-1240	47	6	neutrophils	neutrophil	NOUN
dpc-1240	47	7	,	,	PUNCT
dpc-1240	47	8	and	and	CCONJ
dpc-1240	47	9	plasma	plasma	NOUN
dpc-1240	47	10	cells	cell	NOUN
dpc-1240	47	11	are	be	AUX
dpc-1240	47	12	also	also	ADV
dpc-1240	47	13	present	present	ADJ
dpc-1240	47	14	(	(	PUNCT
dpc-1240	47	15	arrow	arrow	NOUN
dpc-1240	47	16	)	)	PUNCT
dpc-1240	47	17	(	(	PUNCT
dpc-1240	47	18	giemsa	giemsa	NOUN
dpc-1240	47	19	stain	stain	NOUN
dpc-1240	47	20	,	,	PUNCT
dpc-1240	47	21	×400	×400	NOUN
dpc-1240	47	22	)	)	PUNCT
dpc-1240	47	23	.	.	PUNCT
dpc-1240	48	1	figure	figure	VERB
dpc-1240	48	2	3	3	NUM
dpc-1240	48	3	.	.	PUNCT
dpc-1240	48	4	almost	almost	ADV
dpc-1240	48	5	complete	complete	ADJ
dpc-1240	48	6	clearance	clearance	NOUN
dpc-1240	48	7	of	of	ADP
dpc-1240	48	8	the	the	DET
dpc-1240	48	9	leishmaniasis	leishmaniasis	NOUN
dpc-1240	48	10	lesions	lesion	NOUN
dpc-1240	48	11	on	on	ADP
dpc-1240	48	12	the	the	DET
dpc-1240	48	13	left	left	ADJ
dpc-1240	48	14	thigh	thigh	NOUN
dpc-1240	48	15	of	of	ADP
dpc-1240	48	16	the	the	DET
dpc-1240	48	17	patient	patient	NOUN
dpc-1240	48	18	(	(	PUNCT
dpc-1240	48	19	24	24	NUM
dpc-1240	48	20	-	-	PUNCT
dpc-1240	48	21	month	month	NOUN
dpc-1240	48	22	follow	follow	NOUN
dpc-1240	48	23	-	-	PUNCT
dpc-1240	48	24	up	up	NOUN
dpc-1240	48	25	)	)	PUNCT
dpc-1240	48	26	.	.	PUNCT
dpc-1240	49	1	letter	letter	NOUN
dpc-1240	50	1	|	|	ADV
dpc-1240	50	2	dermatol	dermatol	ADJ
dpc-1240	50	3	pract	pract	NOUN
dpc-1240	50	4	concept	concept	NOUN
dpc-1240	50	5	2020;10(3):e2020061	2020;10(3):e2020061	NUM
dpc-1240	50	6	3	3	NUM
dpc-1240	50	7	2019;13(8):e0007708	2019;13(8):e0007708	NUM
dpc-1240	50	8	.	.	PUNCT
dpc-1240	50	9	https://doi.org/10.1371/journal.pntd	https://doi.org/10.1371/journal.pntd	PROPN
dpc-1240	50	10	.	.	PUNCT
dpc-1240	51	1	0007708	0007708	NUM
dpc-1240	52	1	2	2	NUM
dpc-1240	52	2	.	.	PUNCT
dpc-1240	52	3	stamm	stamm	PROPN
dpc-1240	52	4	lv	lv	PROPN
dpc-1240	52	5	.	.	PUNCT
dpc-1240	52	6	human	human	ADJ
dpc-1240	52	7	 	 	SPACE
dpc-1240	52	8	migration	migration	NOUN
dpc-1240	52	9	 	 	SPACE
dpc-1240	52	10	and	and	CCONJ
dpc-1240	52	11	 	 	SPACE
dpc-1240	52	12	leishmaniasis	leishmaniasis	NOUN
dpc-1240	52	13	—	—	PUNCT
dpc-1240	52	14	on	on	ADP
dpc-1240	52	15	the	the	DET
dpc-1240	52	16	move	move	NOUN
dpc-1240	52	17	.	.	PUNCT
dpc-1240	53	1	jama	jama	PROPN
dpc-1240	53	2	dermatol	dermatol	NOUN
dpc-1240	53	3	.	.	PUNCT
dpc-1240	53	4	 	 	SPACE
dpc-1240	54	1	2016;152(4):373	2016;152(4):373	PROPN
dpc-1240	54	2	-	-	SYM
dpc-1240	54	3	374	374	NUM
dpc-1240	54	4	.	.	PUNCT
dpc-1240	55	1	https://doi.org/10.1001/	https://doi.org/10.1001/	PROPN
dpc-1240	55	2	jamadermatol.2015.4765	jamadermatol.2015.4765	PROPN
dpc-1240	55	3	references	reference	NOUN
dpc-1240	55	4	1	1	NUM
dpc-1240	55	5	.	.	PUNCT
dpc-1240	56	1	bosch	bosch	PROPN
dpc-1240	56	2	-	-	PUNCT
dpc-1240	56	3	nicolau	nicolau	PROPN
dpc-1240	56	4	p	p	X
dpc-1240	56	5	,	,	PUNCT
dpc-1240	56	6	ubals	ubal	NOUN
dpc-1240	56	7	m	m	PROPN
dpc-1240	56	8	,	,	PUNCT
dpc-1240	56	9	salvador	salvador	PROPN
dpc-1240	56	10	f	f	PROPN
dpc-1240	56	11	,	,	PUNCT
dpc-1240	56	12	et	et	PROPN
dpc-1240	56	13	al	al	PROPN
dpc-1240	56	14	.	.	PUNCT
dpc-1240	56	15	leishmaniasis	leishmaniasis	PROPN
dpc-1240	56	16	 	 	SPACE
dpc-1240	56	17	and	and	CCONJ
dpc-1240	56	18	tumor	tumor	NOUN
dpc-1240	56	19	necrosis	necrosis	NOUN
dpc-1240	56	20	factor	factor	NOUN
dpc-1240	56	21	alpha	alpha	NOUN
dpc-1240	56	22	antagonists	antagonist	NOUN
dpc-1240	56	23	in	in	ADP
dpc-1240	56	24	the	the	DET
dpc-1240	56	25	mediterranean	mediterranean	PROPN
dpc-1240	56	26	basin	basin	NOUN
dpc-1240	56	27	:	:	PUNCT
dpc-1240	56	28	a	a	DET
dpc-1240	56	29	switch	switch	NOUN
dpc-1240	56	30	in	in	ADP
dpc-1240	56	31	clinical	clinical	ADJ
dpc-1240	56	32	expression	expression	NOUN
dpc-1240	56	33	.	.	PUNCT
dpc-1240	57	1	plos	plos	PROPN
dpc-1240	57	2	negl	negl	PROPN
dpc-1240	57	3	trop	trop	X
dpc-1240	57	4	dis	dis	PROPN
dpc-1240	57	5	.	.	PUNCT
dpc-1240	58	1	https://doi.org/10.1371/journal.pntd.0007708	https://doi.org/10.1371/journal.pntd.0007708	PROPN
dpc-1240	58	2	https://doi.org/10.1371/journal.pntd.0007708	https://doi.org/10.1371/journal.pntd.0007708	PROPN
dpc-1240	58	3	https://doi.org/10.1001/jamadermatol.2015.4765	https://doi.org/10.1001/jamadermatol.2015.4765	PROPN
dpc-1240	58	4	https://doi.org/10.1001/jamadermatol.2015.4765	https://doi.org/10.1001/jamadermatol.2015.4765	PROPN